I have raised, in rabbits, antibodies against MM and BB isoenzymes of creatine kinase. The antibodies produced were homogeneous by Ouchterlony double immunodiffusion and did not cross react with their opposite antigens. Both antisera, however, appeared to be mixtures of antibodies, displaying different equivalences for activation, inactivation, and, possibly, precipitation. Inactivation studies indicated the presence of antibodies effective against dimer only and antibodies effective against monomer or dimer. Both antisera cross reacted with MB and displayed antibodies that appeared to block only half of the activity as well as antibodies that blocked all of the activity. The antisera produced were useful for measuring MB by both immuno-inhibition and immunonephelometry, but neither appears to be advantageous over current electrophoresis or ion-exchange methods. 
I have raised, in rabbits, antibodies against MM and BB isoenzymes of creatine kinase. The antibodies produced were homogeneous by Ouchterlony double immunodiffusion and did not cross react with their opposite antigens. Both antisera, however, appeared to be mixtures of antibodies, displaying different equivalences for activation, inactivation, and, possibly, precipitation. Inactivation studies indicated the presence of antibodies effective against dimer only and antibodies effective against monomer or dimer. Both antisera cross reacted with MB and displayed antibodies that appeared to block only half of the activity as well as antibodies that blocked all of the activity. The antisera produced were useful for measuring MB by both immuno-inhibition and immunonephelometry, but neither appears to be advantageous over current electrophoresis or ion-exchange methods. A comparison of decay of MB in patients between activity and mass measurements indicates that activity decay is about 12-fold faster than mass decay. and immunological methods (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . The selective activation method has been repeatedly shown to be ineffective and unreliable (14) (15) (16) . Although serious problems have been associated with immunological methods (14) , subsequent efforts have indicated that the approach is promising. The methods reported to date have utilized immuno-inhibition (2-6) or radioimmunoassay (7-13).
I report here my experience with rabbit antisera against MM and BB and my efforts at measuring the isoenzymes by laser nephelometry. During this work, a commercial immunoassay became available here and the work was extended to include it. The experimental procedures developed in this study are not proposed as working methods, but are used to explore the potential advantages and disadvantages of immunological measurements of creatine kinase isoenzymes.
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Materials and Methods

Antigen.
Human skeletal and uterine muscle (about 1 kg each) were used as a source for MM and BB antigens, respectively. Purification was achieved essentially as described by Keutel et al. (17) . The purified material was homogeneous by polyacrylamide electrophoresis. A recovery of 16.2 and 9.8 mg of protein was obtained for MM and BB, respectively. Specific activities were 1460 U/mg for MM and 420 U/mg for BB.
Antisera. Rabbits were immunized with 1 mg each of MM or BB in complete Freund's adjuvant, both in the foot-pads and subdermally. Booster injections of 0.5 mg in incomplete Freund's adjuvant were given subdermally every two weeks, and the rabbits were bled about 7-14 days later. Response was monitored by Ouchterlony double immunodiffusion.
Optimum response was obtained with the fourth bleeding and maintained through three additional bleedings. The anti-B antiserum was diluted in five steps to a final concentration of one-half the original concentration with a heat-inactivated (60 #{176}C, 30 min) normal serum pool, followed by incubation for 2 hand clarification by centrifugation and ultra-filtration. The anti-M antiserum was treated the same way, except that the serum pool used was passed through AG-MP5O, Na form (Bio-Rad Laboratories, Richmond, CA 94804) to remove MM.
Measurements.
Creatine except that to increase sensitivity, the adapter for 10-mm tubes was removed to use 13-mm tubes.
Immuno-inhibition.
The fmal working reagent selected was the CK-NAC reagent made to contain an 80-fold dilution of antiserum (anti-MM or anti-BB). The specimen:reagent ratio was 0.04. Preincubation at ambient temperature was for 15 mm, followed by measurement at 37 #{176}C. Specimens were in a serum matrix.
Immunonephelometry. The working reagent was an 80-fold dilution of antiserum in polyethylene glycol 6000 (40 g/L of physiological saline). The specimen:reagent ratio was 0.1. Specimens were in a serum matrix. An initial measurement of light scatter was made immediately after mixing, followed by a second measurement after 30 mm. Antisera and specimen blanks were measured at the same time, although this was not necessary because the initial measurement was stable for 2-3 mm and, in effect, was a combined antisera-specimen blank.
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Results
Antisera
For both MM and BB, immunodiffusion yielded a single major precipitin line with two minor faint lines, indicating responses to more than one immunogen.
After treatment with human sera, both antisera yielded a single precipitin line, indicating that the minor unidentified antibodies had been removed. Titration curves for anti-BB antisera ( Figure 1 ) and corresponding data for anti-MM antisera (Table 1) suggest three equivalence points for each antiserum, particularly for the anti-BB antiserum. This indicates that, although the antisera are homogeneous for MM or BB, they are nevertheless mixtures of antibodies that have mixed reactions with the Cross Reactivity
Neither anti-MM nor anti-BB antisera cross reacted in any way (activating, inhibiting, or precipitating) with its pure opposite antigen. Both, however, cross reacted with MB. Activating cross reactivity for anti-MM was about 6% and for anti-BB about 2%, when measured as a percentage of expected activation at equivalence. Precipitating cross reactivity was about 68% for anti-BB and 48% for anti-MM when measured at 50% maximum relative light scatter. Inhibiting cross reactivity was 92% for anti-BB and 84% for anti-MM, when measured at maximum inhibition. Under conditions of antigen excess (about 200 U/L), based on an estimation of antisera required for 50% inhibition with and without centrifugation, the cross reactivity with MB for the anti-BB antiserum was 74% for precipitation and 87% for inhibition; for the anti-MM 2 A reviewer has indicated that my use of the word "precipitate" is not according to current convention.While nephelometry measures the immune complexes across a spectrum of solubility and insolubility, I have taken the liberty to group these complexes with the precipitates made evident by conventional low speed (2000 rpm, 10 mm) centrifugation. As is evident from Figure 1 , not all of these precipitates are inactive. antiserum, it was 62% for precipitation and 71% for inhibition.
Reaction Rate
The reaction rates for precipitation and inhibition for anti-BB with MB are evident from Figure 2 . Anti-MM with MB (not shown) reacted similarly except that maximum inhibition leveled off at about 16% activity instead of 8% and required about 30 mm to reach maximum inhibition instead of 20 mm. Reaction rates against MM and BB were about twice as fast as the cross reaction rates and attained about 98% inhibition.
Nephelometric Response
Representative response curves for anti-BB with MB and BB are shown in Figure 3 . It is evident that anti-BB antisera can be used successfully to measure BB and MB nephelometrically. Anti-MM antisera with MM and MB has similar response curves (not shown), but this is not very useful, because serum contains primarily MM and it is not possible to resolve MB from MM. The units-pig correspondence is based on a separate study (not presented here) correlating the activity of dilutions of fresh "fully" active homogenates against tg/L concentrations of original antigen preparations, with relative light scatter used to match the data pairs. The regression equation was y = 2.38x -5 where y is activity of the "fully" active dilutions and x is tg/L of original antigen. When compared to the originally determined specific activity of 0.42 U/,ug, this correlation of about 2.3 U/j.ig indicates that at least 82% of the original antigen preparation was enzymatically inactive. This was not unexpected, in view of BB's lability and the harsh treatment to which it was exposed.
lmmuno-lnhibition MB may be measured by the use of a single antiserum, anti-MM or anti-BB, or both antisera. The use of anti-BB alone proved impractical, because it required calculating MB from the difference between two relatively large numbers. When both antisera are used, provided no significant BB is present, the following equations are true:
anti-B treated = 100% MM + 8% MB Figure 4 shows data from only one patient, this observation has been confirmed to be representative, at least, of six out of seven patients. One patient showed a continued increase of apparent MB protein with no concurrent increase in activity.
A comparison of immunoprecipitation (nephelometric) and immuno-inhibition measurements with ion-exchange separation is shown in Figure 5 . In this study I tried to avoid late infarct specimens because these would give the nephelometric measurements a high bias. The nephelometric method (., 
DADE Cardiozyme
Using serum determined to be free of MB or BB by ionexchange and by reaction with the BB antisera reported here, I found that below 100 U/L less than 1.6% of original MM Dilution curves for the fractions used were more linear than those for serum. Nevertheless, the phenomenon of increasing recovery with increasing activity appears to be opposite to the effect of dilution.
With use of actual human sera, provided hemolyzed specimens were omitted, the method correlated quite well (n = 30, YDADE = 2.09x + 12, r = 0.94) with ionexchange separation, although there is a clear low bias, about 40% of the ion-exchange activities (or 80%, when multiplied by two to convert B activity to MB activity). These figures are corrected for difference in reagents. The x-intercept is consistent with poor recovery of low activities. Hemolysis, even when only faintly detectable, results in false apparent MB activity of no less than 20 U/L and generally in the range of
35-80 U/L.
A Table 2 . These data are based on replicate analyses of identical specimens run at the same time and are, therefore, the optimum that can be expected.
Discussion
Although MM and BB were utilized asantigens, the lability of these dimers suggests the antigen in vivo will rapidly become a heterogeneous mixture of dimers, monomers, and fragments, all in various degrees of denaturation.
It is to be expected, then, considering current immune theory, that antibodies will be produced to a multitude of sites, both distorted and otherwise. To my knowledge, there has been no attention in the literature to the heterogeneous antigen-antibody reactions that can be expected from mixtures of antibodies to such heterogeneous sites of CK. Although enzyme-activating antibodies have been reported before (21) , there has been no report of this for CK. The activating antibodies reported here have titers and low cross reactivity for MB, similar to the antibodies reported in radioimmunoassay procedures (12, 13) , which suggests that these may be against similar sites. This inference is also supported by the observation of Roberts et al. (8) that the decay of MB by radioimmunoassay coincides with its activity decay, which is an unexpected observation unless their antibodies were against a fragile geometry involving the active site. Their observation is difficult to explain otherwise, for it would be a remarkable coincidence, in view of its lability, for MB's activity to decay at precisely the same rate at which its mass is being removed from circulation.
The antibodies I raised did not show this decay correlation when used nephelometrically.
The For the purposes of analysis of MB by immuno-inhibition, the DADE antiserum is clearly superior. The immuno-inhibition method available from DADE works well, is easy to use, and gives reliable results, provided no hemolysis is present and the MB is not less than 15 U/L. There is a danger, however, that the method will yield false negatives with low MB concentrations and false positives with high total CK, even if brought within the recommended dilutions. Used inteffigently, however, the method should prove quite useful. The former problem appears to be a matter of sensitivity and a low titer of MB-inactivating antibodies, whereas the latter problem is potentially incomplete inhibition. The sensitivity problem is also aggravated by unexplained negative absorbance change with many sera; this is possibly glutathione reductase interference. It is unfortunate that such a good antiserum was combined with a nonoptimized reagent, the outdated German method (22), which has a poor buffer, the wrong pH, inadequate thiol, NADP, magnesium, ADP, and coupling enzymes. The sensitivity could be improved by using an optimized reagent, and the adenylate kinase interference with hemolysis could be diminished significantly with a better reagent. Because the method requires a 7-mm preincubation, fluoride may be a good choice to minimize adenylate kinase interference.
A method similar to DADE'S was reported by W. Gerhardt et al. (20) , who used what appears to be a better antigenantibody ratio, the Scandinavian formulation (18) , and creatine phosphate initiation with blanking. They report 1% uninhibited MM activity, a requirement that adenylate kinase blank rates be measured, an MB recovery of about 45%, and a CV of 10% at 20 U of MB per liter.
The antisera I raised are better suited for nephelometric measurement than immuno-inhibition. There may be an advantage for the nephelometric method in the prolonged half-life (about 12-fold greater) of MB when measured nephelometrically as compared to activity measurements.
A consideration of immune theory and the lability of MM and BB suggests that immunization will result in antibodies against numerous heterogeneous sites of dimers (which are likely themselves heterogeneous, see ref. 23), monomers, and fragments, structurally similar and alien to the native structures. This should result in antibodies that produce inhibited and uninhibited precipitates, and nonprecipitating antibodies that inhibit whole dimers only, half dimers only, or both. Some of these complexes could conceivably produce structurally more accessible active sites, resulting in activation. My experiments were exploratory and not designed to assess these possibilities, but they suggest that these heterogeneously acting antibodies not only exist but are potentially resolvable. Thus it should be possible to isolate from a mixture of anti-MM or anti-BB antibodies a component antibody or antibodies specific against MB only.
